Track the 페니트리움바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 페니트리움바이오 has recorded 42 public disclosures. Market capitalisation: €274.1bn. The latest transaction was filed on 18 June 2026 (Other). Among the most active insiders: 모비스. The full history is openly available.
42
Insider Decl.
0
Thresholds
·
5 ops.
Buy Volume
·
12 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,624 of 25,596 companies
13.9
score / 100
Value
25
Quality
3
FCF yld-2.1%
Earn yld-5.9%
EV/EBITDA·
ROE-89%
Gross mgn0.4%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
페니트리움바이오 operates in the healthcare and pharmaceutical sector, listed on the XKRX market. The company focuses on developing innovative biopharmaceutical solutions.